Skip links

Genetic Engineering & Biotechnology News – Article

Our thanks to Genetic Engineering & Biotechnology News for featuring OncoOne’s CEO and Co-founder, Randolf Kerschbaumer, in an article highlighting the potential of multispecific antibody technologies, including our PreTargit® platform. Visit the link below to read the article and discover how we are developing our modular pre-targeted radioimmunotherapy to address a variety of hard-to-treat cancers.

https://www.genengnews.com/topics/cancer/multispecific-antibodies-come-to-grips-with-manifold-targets/

Home